- Report
- January 2025
- 186 Pages
Global
From €4449EUR$4,995USD£3,825GBP
- Report
- October 2023
- 265 Pages
Global
€4093EUR$4,595USD£3,518GBP
- Report
- July 2025
- 217 Pages
Global
From €4449EUR$4,995USD£3,825GBP
- Report
- August 2026
- 160 Pages
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- August 2026
- 160 Pages
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- August 2026
- 160 Pages
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- August 2026
- 160 Pages
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- August 2025
- 150 Pages
Global
From €2815EUR$3,160USD£2,420GBP
€3518EUR$3,950USD£3,025GBP
- Report
- June 2025
- 147 Pages
Global
From €3518EUR$3,950USD£3,025GBP
- Report
- May 2026
- 150 Pages
Japan
From €4320EUR$4,850USD£3,714GBP
- Report
- May 2026
- 150 Pages
Malaysia
From €4320EUR$4,850USD£3,714GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4320EUR$4,850USD£3,714GBP
- Report
- May 2026
- 150 Pages
Spain
From €4320EUR$4,850USD£3,714GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4320EUR$4,850USD£3,714GBP
- Report
- May 2026
- 150 Pages
Canada
From €4320EUR$4,850USD£3,714GBP
- Report
- May 2026
- 150 Pages
Germany
From €4320EUR$4,850USD£3,714GBP
- Report
- March 2026
- 381 Pages
China
From €4320EUR$4,850USD£3,714GBP
- Report
- March 2026
- 170 Pages
Germany
From €4320EUR$4,850USD£3,714GBP
- Report
- March 2026
- 342 Pages
Canada
From €4320EUR$4,850USD£3,714GBP
- Report
- March 2026
- 209 Pages
India
From €4320EUR$4,850USD£3,714GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more